Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Abstract 5025: Immune expression profiling of MAPK inhibitor resistant tumors based upon mechanisms of resistance
Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.
Abstract 4864: Targeted melanoma therapies as radiosensitizers
